Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal
Filter by:
Health-Care Watchdog to Review Medicaid Opioid Claims
July 18, 2017
Ellyn Sternfield, a Health Law attorney and Special Counsel in the Mintz Washington, D.C. office, is quoted in a Bloomberg BNA Health Law Reporter article discussing new plans for the Office of Inspector General (OIG) of the Department of Health and Human Services.
Plan To Cut Legal Immigration Likely To Be Uphill Battle
July 17, 2017
Susan Cohen, founder and Chair of Mintz’s Immigration Practice, is quoted in this Law360 article on the impact a proposed immigration bill will have on legal immigration. The article notes that the bill will be difficult to pass through Congress, but could still have a “chilling effect”.
The Dos and Don’ts Of Minimizing Risk For TCPA Liability
July 14, 2017
Joshua Briones, Managing Member in Mintz’s Los Angeles office and Crystal Lopez, a Litigation Associate, authored a Law360 article on the importance for businesses to be vigilant about internal and third-party Telephone Consumer Protection Act (TCPA) compliance.
ML Strategies Welcomes Massachusetts Legislator Brian Dempsey as Senior Vice President and Chief Operating Officer
July 13, 2017
Veteran legislator Brian S. Dempsey, Chairman of the Committee on Ways and Means in the Massachusetts House of Representatives, is joining ML Strategies. Mr. Dempsey will serve as Senior Vice President and COO.
Bruins beat the IRS at tax shootout
July 7, 2017
Scott Pinarchick, a Member and business lawyer in the Mintz Boston office, was quoted in a Boston Globe article highlighting a U.S. Tax Court decision allowing the Bruins to deduct the cost of all meals eaten by the team while traveling for games.
Mintz Attorney Says New FDA Organizational Changes Could Have Big Food Industry Effects
July 5, 2017
The Food and Drug Administration quietly announced and enacted significant organizational changes. FDA and Health Law attorney Joanne Hawana is quoted in this article discussing the potential impacts of these changes could include faster FDA factory inspections and audits.